SEC31 Homolog A

SEC31Agene

SEC31A differential expression distinguishes ischemic Type 1 MI pathophysiology from hemodynamic overload.

Pathway placement

Cascade stepMyocardial injury (shared endpoint)

Confidencelow

RationaleDifferentially regulated between ischemic and pressure-overload injury models; MI-specific signature.

Druggability

DruggableYes

Known drugs / candidates0

Small-molecule tractableNo

Antibody tractableYes

EnsemblENSG00000138674

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.

Specimen

Whole blood — gene is not a circulating analyte; measure protein product or genotype

Collection tube

K2-EDTA whole blood (lavender-top)

Method / principle

SNP genotyping / sequencing; or immunoassay of encoded protein

Reagent / substrate

Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein

Platform

qPCR / NGS / array

Turnaround · availability

Send-out · Genotyping widely available; protein assay variable